Search

Welcome to Saul Ewing’s Public Companies Quarterly Update series. Our intent is to, on a quarterly basis, highlight important legal developments of which we think public companies should be aware. This edition is related to developments during the fourth quarter of 2023. If you would like to discuss...

Once public, a company is subject to a continuously evolving landscape of disclosure and reporting requirements. Recent disclosure developments have addressed everything from executive compensation to cybersecurity. In addition, the prevalence of social media has made it such that a company must now...

Stocks and bonds are easily recognizable as securities, but did you know that promissory notes may also be securities? So can certain joint venture interests and many other types of investment contracts. Then there are cryptocurrency altcoins, which are sometimes securities and sometimes not. How do...

This webinar will present a summary and analysis of 2023 developments and actions by the U.S. Securities and Exchange Commission and a forward-looking discussion of what to expect in the year ahead.

The private capital markets have become an increasingly important source of funding for both private and public companies alike. Today total capital raised through private placements surpasses total capital raised in public offerings. What’s more, in recent years legislation like the JOBS Act has...

Welcome to Saul Ewing’s Public Companies Quarterly Update series. Our intent is to, on a quarterly basis, highlight important legal developments of which we think public companies should be aware. This edition is related to developments during the second quarter of 2023. If you would like to discuss...

Saul Ewing LLP represented Genesis Unicorn Capital, LLC, in its acquisition of and role as the sole sponsor for Genesis Unicorn Capital Corp. a special purpose acquisition company (SPAC), in the SPAC's $75 Million initial public offering (IPO) of 7,500,000 units at a price of $10.00 per unit. The...

Saul Ewing LLP represented Signal Hill Acquisition Corp., a special purpose acquisition company, in its initial public offering of 10,000,000 units at a price of $10.00 per unit, resulting in gross proceeds of $100,000,000. The units are listed on The Nasdaq Global Market (Nasdaq) and began trading...

Extensive Government and Internal Investigation Experience. Notable Results. White collar defense and regulatory issues can arise without warning, and require experience, finesse, and judgment to resolve favorably. Whether it is a search warrant, “target letter,” “Wells Notice,” subpoena...

Eric Orlinsky concentrates his practice in general business and securities law and counsels clients in private equity and venture capital investments, public and private offerings of debt and equity securities, mergers and acquisitions, purchases and sales of businesses. Eric also provides general...

Charlie Lizza brings more than 40 years of litigation experience to his representation of pharmaceutical companies in high stakes patent litigation. Mr. Lizza concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical and medical...

Maja Ilic is a seasoned capital markets and corporate attorney who helps domestic and foreign issuers navigate public and private debt and equity securities offerings, including IPO and SPAC transactions. With extensive experience in both law firm and in-house roles, along with fluency in multiple...

Irfan Malani litigates intellectual property disputes, including matters involving patents, trademarks, and trade secrets. His experience includes cases covering a wide array of technologies and industries, from telecommunications and medical devices to cybersecurity. In addition to representing...

Jim Taylor is a trial lawyer with first-chair experience handling complex litigation in federal and state courts. A significant portion of his practice uses that litigation experience and perspective to counsel clients in managing high-profile crises, minimizing financial and reputational risks...

Government is growing every day. Regardless of which political party is in power, the scope of government regulation at the state, county and local levels, and the impact of government on all types of business has regularly increased. Regardless of your type of business – manufacturing or finance...

Protecting the Rights of Corporate Clients Companies generally enjoy a fruitful relationship with their shareholders, but disagreements about management, perceptions of minority shareholder mistreatment, or concerns over executive compensation may arise. No matter the cause of shareholder...

Christie McGuinness focuses her practice on commercial litigation and disputes involving force majeure and white collar and government enforcement. Christie represents clients in a wide range of industries in cases alleging breach of contract and breach of fiduciary duty as well as disputes arising...

The pharmaceutical industry faces a challenging business environment as competition drives down prices, R&D expenses rise, and government scrutiny deepens. However, companies have many options for navigating these challenges, generally by making deals with others in the field, including mergers and...